title: Pharmacological blockade and genetic absence of the dopamine D2 receptor specifically modulate voluntary locomotor activity in mice.
abstract: Dopaminergic signaling influences physical activity. Notably impaired D2 receptor (D2R) function has been associated with decreased voluntary physical activity. Most animal models investigating effects of genetic or pharmacological dopaminergic modulation measure physical activity for a limited time of up to few hours. The aim of this study is to investigate the impact of chronic or acute D2R dysfunction on physical activity over several days. For this purpose, we used a highly automated running wheel system to continuously record physical activity in mice. We found that D2R-knockout status led to a permanent decrease of running wheel activity. In contrast, acute D2R blockade by raclopride (1.5-5mg/kg) resulted in an initial dose-dependent reduction of running wheel usage and a compensating increase of activity in later stages of the activity phase. This indicates that D2R dysfunction reduces physical activity. Our data indicate that this reduction to a large extent cannot be explained by motor deficits. The delayed increase of activity after D2R blockade might be due to a rebound effect.
authors.affiliation: Clinical Neurophysiology, University Medical Centre, Georg-August-University, Göttingen, Germany. fklinker@med.uni-goettingen.de
authors.forename: Florian
authors.initials: F
authors.lastname: Klinker
authors.forename: Kenan
authors.initials: K
authors.lastname: Hasan
authors.forename: Walter
authors.initials: W
authors.lastname: Paulus
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nitsche
authors.forename: David
authors.initials: D
authors.lastname: Liebetanz
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D018492:Dopamine Antagonists / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D008124:Locomotion / Q000187:drug effects* / Q000235:genetics*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009043:Motor Activity / Q000187:drug effects / Q000235:genetics; D020891:Raclopride / Q000494:pharmacology*; D017448:Receptors, Dopamine D2 / Q000172:deficiency*; D013997:Time Factors
chemical_list: D018492:Dopamine Antagonists; D017448:Receptors, Dopamine D2; D020891:Raclopride